US Patent 9090694 ST2L antibody antagonists
Patent 9090694 was granted and assigned to Janssen Biotech on July, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+175 characters)
Article
Patent abstract
The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09090694 ST2L antibody antagonists US Patent 9090694 ST2L antibody antagonists
Infobox
Patent Number
090906940
Patent Number
90906940
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
090906940
Date of Patent
July 28, 2015
0Patent Application Number
137982040
Date Filed
March 13, 2013
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09090694 ST2L antibody antagonists
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09090694
Date of patent
July 28, 2015
Patent application number
13798204
Date Filed
March 13, 2013
Patent primary examiner
Find more entities like US Patent 9090694 ST2L antibody antagonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
